Deltagen

Deltagen EBIT

The EBIT of Deltagen (DGEN) as of Nov 19, 2026 is -46,000.00 USD. In the previous year, EBIT was 77,000.00 USD — a change of -159.74% (lower).

EBIT

-46,000.00USD

YoY

-159.74%

Last updated:

In 2015, Deltagen's EBIT was -46,000.00 USD, a -159.74% increase from the 77,000.00 USD EBIT recorded in the previous year.

The Deltagen EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2008
69,000.00 USD
Jan 1, 2009
-703,000.00 USD
Jan 1, 2010
-694,000.00 USD
Jan 1, 2011
-2.85 M USD
Jan 1, 2012
-53,000.00 USD
Jan 1, 2013
112,000.00 USD
Jan 1, 2014
77,000.00 USD
Jan 1, 2015
-46,000.00 USD
The Deltagen EBIT history
YEAREBITYoY
-46,000.00USD-159.74%
77,000.00USD-31.25%
112,000.00USD-311.32%
-53,000.00USD-98.14%
-2.85 MUSD+310.09%
-694,000.00USD-1.28%
-703,000.00USD-1,118.84%
69,000.00USD-127.27%
-253,000.00USD-106.40%
3.96 MUSD+757.92%
461,000.00USD-99.57%
107.86 MUSD+106.77%
52.16 MUSD+47.97%
35.25 MUSD+154.77%
13.84 MUSD-482.21%
-3.62 MUSD+178.46%
-1.30 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Deltagen Revenue

Deltagen Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2008
2.93 M USD
69,000.00 USD
37,000.00 USD
Jan 1, 2009
1.36 M USD
-703,000.00 USD
-687,000.00 USD
Jan 1, 2010
1.99 M USD
-694,000.00 USD
-685,000.00 USD
Jan 1, 2011
902,000.00 USD
-2.85 M USD
-2.84 M USD
Jan 1, 2012
1.05 M USD
-53,000.00 USD
-1.17 M USD
Jan 1, 2013
1.02 M USD
112,000.00 USD
-4.42 M USD
Jan 1, 2014
263,000.00 USD
77,000.00 USD
76,000.00 USD
Jan 1, 2015
770,000.00 USD
-46,000.00 USD
-46,000.00 USD

Deltagen Margins

Deltagen stock margins

The Deltagen margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Deltagen. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Deltagen.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2008
99.48 %
2.36 %
1.26 %
Jan 1, 2009
99.48 %
-51.81 %
-50.63 %
Jan 1, 2010
99.48 %
-34.93 %
-34.47 %
Jan 1, 2011
73.61 %
-315.52 %
-315.19 %
Jan 1, 2012
67.46 %
-5.03 %
-110.53 %
Jan 1, 2013
64.58 %
10.96 %
-432.29 %
Jan 1, 2014
29.28 %
29.28 %
28.90 %
Jan 1, 2015
99.48 %
-5.97 %
-5.97 %

Deltagen Stock analysis

What does Deltagen do? Deltagen Inc is a leading biotechnology company focused on drug discovery and the development of novel therapies. The company was founded in 1996 by a group of scientists and is headquartered in San Francisco, California. The founders recognized the potential of genetic research and developed innovative technologies for identifying target molecules for drug development. Over the years, they acquired numerous patents and heavily invested in research and development. Deltagen Inc specializes in two core areas: genomic research and drug discovery. In the field of genomic research, the company offers services for systematic analysis of gene functions. This includes identification of target molecules, development of drug candidates, and validation of drug targets. In the field of drug discovery, Deltagen Inc focuses on developing novel therapies for a variety of diseases. The company utilizes advanced technologies and innovative research approaches to identify and validate potential drug candidates. Their goal is to develop groundbreaking medications that significantly improve patient's lives. Another important area of Deltagen Inc is diagnostics. The company offers tests for various diseases, including cancer, neurological disorders, and metabolic disorders. These tests are based on genetic analysis and can aid in early detection of diseases and enable targeted treatment. Deltagen Inc works closely with the pharmaceutical industry and other partners to advance drug development. The company has established numerous collaborations and licensing agreements with leading pharmaceutical companies and offers a wide range of products and services for drug development. Deltagen Inc's products include antibodies and other biomolecules that can be used for the treatment of diseases such as cancer, autoimmune disorders, and infectious diseases. The company also develops innovative therapy approaches based on RNA interference and gene therapy. Deltagen Inc is a company with a strong culture of innovation, constantly striving to explore new avenues and evolve. The founders and the entire team have a passion for science and the potential it has for improving the health and well-being of people. Deltagen Inc emphasizes close collaboration with customers and partners to jointly develop and market innovative solutions. The company takes pride in being part of an industry that contributes to improving the lives of patients worldwide. Deltagen is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Deltagen's EBIT

Deltagen's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Deltagen's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Deltagen's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Deltagen’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Deltagen stock

EBIT of Deltagen is -46,000.00 USD in 2015.

EBIT of Deltagen changed from 77,000.00 USD to -46,000.00 USD, representing a -159.74% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Deltagen since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Deltagen historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Deltagen

All Key Metrics — Deltagen